Tweet
2020-08-23 10:10:34Beijing News
my country has officially launched the emergency use of the new crown vaccine on July 22
Beijing News Express According to the WeChat official account of China National Biotechnology Co., Ltd., on August 22, the vaccine research and development team of the Joint Prevention and Control Mechanism of the State Council and relevant experts including researcher Yang Xiaoming were interviewed by the media. Interpret related issues.
The emergency use of the new crown vaccine was officially launched on July 22
Zheng Zhongwei, director of the Science and Technology Development Center of the National Health Commission and the leader of the vaccine research and development team of the Joint Prevention and Control Mechanism of the State Council, said in the program that my country has officially launched the emergency use of the new crown vaccine on July 22.
The "Vaccine Management Law" clearly stipulates that when a particularly major public health event occurs, the National Health Commission shall submit an application for emergency use of vaccines, and the State Food and Drug Administration shall organize experts to discuss and agree, and the National Health Commission shall set a certain scope and time limit. Emergency use of vaccines. The purpose is to first establish an immune barrier among special populations such as medical personnel, epidemic prevention personnel, border inspection personnel, and personnel who guarantee basic urban operations, so that the operation of the entire city will have a stable guarantee.
New crown vaccine phase III clinical trial enrolls more than 20,000 people
The Phase III clinical study is an important step related to whether the vaccine can be marketed for mass population vaccination. Yang Xiaoming, Chairman of Sinopharm Group China Biologics and chief scientist of the national "863" plan vaccine project, said that on June 23, the launch ceremony of the International Clinical (Phase III) China Biologics New Coronary Inactivated Vaccine in the United Arab Emirates took place in Beijing, Wuhan, and Abu Dhabi, UAE. Compared with the three places, the video conference is held simultaneously. Up to now, the number of people enrolled in the group has exceeded 20,000, and has created many global firsts; the safety is very good, and the effectiveness is under further observation; the enrollment speed is better than expected, which is very worth looking forward to.
On August 20 and August 21, Sinopharm Sinopharm signed cooperation agreements with Peru, Morocco and Argentina on phase III clinical trials of the new crown inactivated vaccine and held the launch ceremony. This marks the overall acceleration of the Phase III clinical trials of China's new biological new crown inactivated vaccine. More sample sizes and clinical trial data in different regions will greatly enhance the listing process of the new crown inactivated vaccine, and contribute Chinese wisdom and strength to the community of human destiny and the health and well-being of people around the world.
